Exact Mass: 412.12597719999997

Exact Mass Matches: 412.12597719999997

Found 62 metabolites which its exact mass value is equals to given mass value 412.12597719999997, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Cyflufenamid

Cyflufenamide

C20H17F5N2O2 (412.12101219999994)


D016573 - Agrochemicals D010575 - Pesticides

   
   

4-Methylamino-4-de(dimethylamino)anhydrotetracycline

4-Methylamino-4-de(dimethylamino)anhydrotetracycline

C21H20N2O7 (412.127045)


   

O-Deethylated candesartan

2-Hydroxy-1-{[2-(2H-1,2,3,4-tetrazol-5-yl)-[1,1-biphenyl]-4-yl]methyl}-1H-1,3-benzodiazole-7-carboxylate

C22H16N6O3 (412.1283826)


O-Deethylated candesartan is only found in individuals that have used or taken Candesartan.O-Deethylated candesartan is a metabolite of Candesartan. O-deethylated candesartan belongs to the family of Biphenyltetrazoles and Derivatives. These are organic compounds containing a biphenyl attached to a tetrazole. A carbon atom of the biphenyl moiety is boned to a carbon or the nitrogen atom of the tetrazole moiety.

   

(2S,3S,4S,5R)-6-(Benzo[b][1]benzazepine-11-carbonylamino)-3,4,5-trihydroxyoxane-2-carboxylic acid

(2S,3S,4S,5R)-6-[({2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,9,11,13-heptaen-2-yl}(hydroxy)methylidene)amino]-3,4,5-trihydroxyoxane-2-carboxylic acid

C21H20N2O7 (412.127045)


   

Nigrosin

8-amino-7-[2-(4-nitrophenyl)diazen-1-yl]-2-(2-phenyldiazen-1-yl)naphthalen-1-ol

C22H16N6O3 (412.1283826)


   

Patamostat

4-{[2-(2,5-dioxopyrrolidin-1-yl)ethyl]sulfanyl}phenyl 4-[(diaminomethylidene)amino]benzoate

C20H20N4O4S (412.12052000000006)


   

PYRAOXYSTROBIN

Methyl 2-[2-({[3-(4-chlorophenyl)-1-methyl-1H-pyrazol-5-yl]oxy}methyl)phenyl]-3-methoxyprop-2-enoic acid

C22H21ClN2O4 (412.11897760000005)


   
   
   
   

S-Ferulyl-N-gamma-glutamylcysteine

S-Ferulyl-N-gamma-glutamylcysteine

C18H24N2O7S (412.1304154)


   

N6-Threonylcarbamoyladenosine

N6-Threonylcarbamoyladenosine

C15H20N6O8 (412.134256)


CONFIDENCE standard compound; INTERNAL_ID 308

   

Bisphenol A bis(3-chloro-2-hydroxypropyl) ether

2,2-bis[4-(3-chloro-2-hydroxypropoxy)phenyl]propane

C21H26Cl2O4 (412.12080560000004)


CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 5813

   

4-(Dimethylamino)-1,4,4a,5,12,12a-hexahydro-3,10,11,12a-tetrahydroxy-1,12-dioxo-2-naphthacenecarboxamide

4-(Dimethylamino)-1,4,4a,5,12,12a-hexahydro-3,10,11,12a-tetrahydroxy-1,12-dioxo-2-naphthacenecarboxamide

C21H20N2O7 (412.127045)


   

8-deacetylcentaurepensin-8-O-(4-hydroxy)tiglate|8-deacylcentaurepensin 8-O-(4-hydroxy)-tiglate|8-desacetylcentaurepensin-8-O-(4-hydroxytiglinate)

8-deacetylcentaurepensin-8-O-(4-hydroxy)tiglate|8-deacylcentaurepensin 8-O-(4-hydroxy)-tiglate|8-desacetylcentaurepensin-8-O-(4-hydroxytiglinate)

C20H25ClO7 (412.128873)


   
   

(S)-2-amino-5-((R)-1-carboxy-2-((E)-3-(4-hydroxy-3-methoxy-phenyl)allylthio)ethyl-amino)-5-oxopentanoic acid|N-L-gamma-glutamyl-S-coniferyl-L-cysteine

(S)-2-amino-5-((R)-1-carboxy-2-((E)-3-(4-hydroxy-3-methoxy-phenyl)allylthio)ethyl-amino)-5-oxopentanoic acid|N-L-gamma-glutamyl-S-coniferyl-L-cysteine

C18H24N2O7S (412.1304154)


   
   

15-bromo-7,16,19-trihydroxy-9(11)-pargueren-2-one

15-bromo-7,16,19-trihydroxy-9(11)-pargueren-2-one

C20H29BrO4 (412.12490940000004)


   

(1R,3S,4S,5S,6S,7R,8S)-4beta-(chloromethyl)-3beta,4alpha-dihydroxy-8alpha-(sarracenoyloxy)-1alphaH,5alphaH,6betaH,7alphaH-guai-10(14),11(13)-dien-6,12-olide

(1R,3S,4S,5S,6S,7R,8S)-4beta-(chloromethyl)-3beta,4alpha-dihydroxy-8alpha-(sarracenoyloxy)-1alphaH,5alphaH,6betaH,7alphaH-guai-10(14),11(13)-dien-6,12-olide

C20H25ClO7 (412.128873)


   

C19H24O8S_3-[(11,13-Dihydroxy-4-methyl-2,10-dioxo-1,4,5,6,7,8,9,10-octahydro-2H-3-benzoxacyclododecin-8-yl)sulfanyl]-2-hydroxypropanoic acid

NCGC00380419-01_C19H24O8S_3-[(11,13-Dihydroxy-4-methyl-2,10-dioxo-1,4,5,6,7,8,9,10-octahydro-2H-3-benzoxacyclododecin-8-yl)sulfanyl]-2-hydroxypropanoic acid

C19H24O8S (412.1191824)


   

O-Deethylated candesartan

2-hydroxy-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-1,3-benzodiazole-7-carboxylic acid

C22H16N6O3 (412.1283826)


   

T6A [ABBR]

(2S,3R)-2-[({9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-6-yl}carbamoyl)amino]-3-hydroxybutanoic acid

C15H20N6O8 (412.134256)


   

Dipyrrolidino(N-succinimidyloxy)carbenium hexafluorophosphate

Dipyrrolidino(N-succinimidyloxy)carbenium hexafluorophosphate

C13H21F6N3O3P (412.12246580000004)


   

9,18-DIHYDROBENZO[H]BENZO[7,8]QUINO[2,3-B]ACRIDINE-7,16-DIONE

9,18-DIHYDROBENZO[H]BENZO[7,8]QUINO[2,3-B]ACRIDINE-7,16-DIONE

C28H16N2O2 (412.12117159999997)


   

4-(Benzyloxy)-6-[(benzyloxy)carbonyl]-2-naphthoic acid

4-(Benzyloxy)-6-[(benzyloxy)carbonyl]-2-naphthoic acid

C26H20O5 (412.13106700000003)


   

Nizofenone

Nizofenone

C21H21ClN4O3 (412.13021060000005)


N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent D020011 - Protective Agents

   

(tert-butoxycarbonylmethyl)triphenylphosphonium chloride

(tert-butoxycarbonylmethyl)triphenylphosphonium chloride

C24H26ClO2P (412.13588560000005)


   

(3-Bromo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)(tert-butyl)dimethylsilane

(3-Bromo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)(tert-butyl)dimethylsilane

C18H30BBrO3Si (412.12405199999995)


   

Morantel citrate

Morantel citrate salt

C18H24N2O7S (412.1304154)


   

3-(4-Butoxyphenyl)-7-phenylfuro[2,3-f][1]benzofuran-2,6-dione

3-(4-Butoxyphenyl)-7-phenylfuro[2,3-f][1]benzofuran-2,6-dione

C26H20O5 (412.13106700000003)


   
   
   

Dichlorisone

Dichlorisone

C21H26Cl2O4 (412.12080560000004)


C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid

   

Patamostat

Patamostat

C20H20N4O4S (412.12052000000006)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

O-Desethyl Candesartan

O-Desethyl Candesartan

C22H16N6O3 (412.1283826)


A benzimidazolecarboxylic acid that is candesartan in which the ethoxy group has been replaced by a hydroxy group. It is the inactive metabolite of the anti-hypertensive drug, candesartan.

   

3-(2,5-dimethoxyphenyl)-6-(3,4-dimethoxyphenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine

3-(2,5-dimethoxyphenyl)-6-(3,4-dimethoxyphenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine

C20H20N4O4S (412.12052000000006)


   

4-(3,4-dihydro-2H-quinolin-1-ylsulfonyl)-N-(5-ethyl-1,3,4-oxadiazol-2-yl)benzamide

4-(3,4-dihydro-2H-quinolin-1-ylsulfonyl)-N-(5-ethyl-1,3,4-oxadiazol-2-yl)benzamide

C20H20N4O4S (412.12052000000006)


   

N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-[methyl-(phenylmethyl)sulfamoyl]benzamide

N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-[methyl-(phenylmethyl)sulfamoyl]benzamide

C20H20N4O4S (412.12052000000006)


   

4-(dipropylsulfamoyl)-N-[5-[(methylthio)methyl]-1,3,4-oxadiazol-2-yl]benzamide

4-(dipropylsulfamoyl)-N-[5-[(methylthio)methyl]-1,3,4-oxadiazol-2-yl]benzamide

C17H24N4O4S2 (412.1238904)


   
   

(4S,4aS,12aS)-3,10,11,12a-tetrahydroxy-6-methyl-4-(methylamino)-1,12-dioxo-4a,5-dihydro-4H-tetracene-2-carboxamide

(4S,4aS,12aS)-3,10,11,12a-tetrahydroxy-6-methyl-4-(methylamino)-1,12-dioxo-4a,5-dihydro-4H-tetracene-2-carboxamide

C21H20N2O7 (412.127045)


   

methyl (Z)-2-[2-[[5-(4-chlorophenyl)-2-methylpyrazol-3-yl]oxymethyl]phenyl]-3-methoxyprop-2-enoate

methyl (Z)-2-[2-[[5-(4-chlorophenyl)-2-methylpyrazol-3-yl]oxymethyl]phenyl]-3-methoxyprop-2-enoate

C22H21ClN2O4 (412.11897760000005)


   

D-xylotriono-1,5-lactone

D-xylotriono-1,5-lactone

C15H24O13 (412.1216854)


   

Cyclic 8-piperidino-3,5-AMP

Cyclic 8-piperidino-3,5-AMP

C15H21N6O6P (412.1260136)


   

2-ethoxy-N-[4-[(4-methyl-2-pyrimidinyl)sulfamoyl]phenyl]benzamide

2-ethoxy-N-[4-[(4-methyl-2-pyrimidinyl)sulfamoyl]phenyl]benzamide

C20H20N4O4S (412.12052000000006)


   

2-[[5-(3-aminophenyl)-4-methyl-1,2,4-triazol-3-yl]thio]-1-(9H-fluoren-2-yl)ethanone

2-[[5-(3-aminophenyl)-4-methyl-1,2,4-triazol-3-yl]thio]-1-(9H-fluoren-2-yl)ethanone

C24H20N4OS (412.135775)


   

4-[[4-(Benzenesulfonyl)-1-piperazinyl]-oxomethyl]-2-methyl-1-phthalazinone

4-[[4-(Benzenesulfonyl)-1-piperazinyl]-oxomethyl]-2-methyl-1-phthalazinone

C20H20N4O4S (412.12052000000006)


   

N-(((Cyclopropylmethoxy)imino)(2,3-difluoro-6-(trifluoromethyl)phenyl)methyl)-2-phenylacetamide

N-(((Cyclopropylmethoxy)imino)(2,3-difluoro-6-(trifluoromethyl)phenyl)methyl)-2-phenylacetamide

C20H17F5N2O2 (412.12101219999994)


   

N-[(9-beta-D-ribofuranosylpurin-6-yl)carbamoyl]threonine

N-[(9-beta-D-ribofuranosylpurin-6-yl)carbamoyl]threonine

C15H20N6O8 (412.134256)


An N-(adenosin-N(6)-ylcarbonyl)threonine in which the threonine portion has L-configuration.

   

desmethylanhydrotetracycline zwitterion

desmethylanhydrotetracycline zwitterion

C21H20N2O7 (412.127045)


A zwtterion obtained by transfer of a proton from the 2-hydroxy to the secondary amino group of desmethylanhydrotetracycline. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

   

desmethylanhydrotetracycline

desmethylanhydrotetracycline

C21H20N2O7 (412.127045)


A member of the class of tetracyclines that is anhydrotetracycline in which one of the methyl groups attached to the nitrogen has been replaced by hydrogen.

   
   

15-LOX-1 inhibitor 1

15-LOX-1 inhibitor 1

C22H21ClN2O4 (412.11897760000005)


15-LOX-1 inhibitor 1 is a potent inhibitor of 15-LOX-1 (15-lipoxygenase-1) with an IC50 value of 0.19 μM. 15-LOX-1 inhibitor 1 protects macrophages from lipopolysaccharide-induced cytotoxicity. 15-LOX-1 inhibitor 1 inhibits NO formation and lipid peroxidation[1].

   

NSC45586 (sodium)

NSC45586 (sodium)

C20H17N6NaO3 (412.12597719999997)


NSC45586 sodium is an inhibitor of pleckstrin homology domain and leucine-rich repeat protein phosphatase (PHLPP). NSC45586 sodium targets the PP2C phosphatase domain in PHLPP1 and PHLPP2. NSC45586 sodium can activate AKT in neurons[1].

   

5-(1-bromo-2-hydroxyethyl)-3-hydroxy-1a-(hydroxymethyl)-5,7b-dimethyl-1h,1bh,2h,3h,3ah,4h,6h,8h,9ah-cyclopropa[a]phenanthren-9-one

5-(1-bromo-2-hydroxyethyl)-3-hydroxy-1a-(hydroxymethyl)-5,7b-dimethyl-1h,1bh,2h,3h,3ah,4h,6h,8h,9ah-cyclopropa[a]phenanthren-9-one

C20H29BrO4 (412.12490940000004)


   

(3ar,4s,6ar,8s,9s,9as,9bs)-9-(chloromethyl)-8,9-dihydroxy-3,6-dimethylidene-2-oxo-octahydroazuleno[4,5-b]furan-4-yl (2e)-2-(hydroxymethyl)but-2-enoate

(3ar,4s,6ar,8s,9s,9as,9bs)-9-(chloromethyl)-8,9-dihydroxy-3,6-dimethylidene-2-oxo-octahydroazuleno[4,5-b]furan-4-yl (2e)-2-(hydroxymethyl)but-2-enoate

C20H25ClO7 (412.128873)